ELCHIN GAJIEV: Open Payments
NPI 1821001843 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,228 in 32 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $704 · 2025 $1,228
Food & beverage: $1,228
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $550 |
| Neos Therapeutics, LP | 1 | $225 |
| Axsome Therapeutics, Inc. | 6 | $146 |
| Eisai Inc. | 4 | $103 |
| Neurocrine BioSciences, Inc. | 3 | $83 |
| Azurity Pharmaceuticals, Inc. | 3 | $55 |
| ABBVIE INC. | 2 | $45 |
| Lundbeck LLC | 1 | $20 |
Products named: REXULTI, EXXUA, Auvelity, Leqembi, INGREZZA, HORIZANT, VRAYLAR.
Industry payments across NY — which companies pay providers there.
